How Many MTBC, Inc. (NASDAQ:MTBC)’s Analysts Are Bearish?

MTBC, Inc. (NASDAQ:MTBC) Logo

MTBC, Inc. (NASDAQ:MTBC) Ratings Coverage

Among 2 analysts covering Medical Transcription Billing (NASDAQ:MTBC), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Medical Transcription Billing has $7.5 highest and $6 lowest target. $6.75’s average target is 56.98% above currents $4.3 stock price. Medical Transcription Billing had 2 analyst reports since March 15, 2019 according to SRatingsIntel. The stock of MTBC, Inc. (NASDAQ:MTBC) has “Buy” rating given on Friday, March 15 by Dougherty. The stock of MTBC, Inc. (NASDAQ:MTBC) earned “Buy” rating by H.C. Wainwright on Thursday, March 21. Below is a list of MTBC, Inc. (NASDAQ:MTBC) latest ratings and price target changes.

21/03/2019 Broker: H.C. Wainwright Rating: Buy New Target: $6 Maintain
15/03/2019 Broker: Dougherty Rating: Buy New Target: $7.5 Initiate

The stock decreased 2.05% or $0.09 during the last trading session, reaching $4.3. About 26,594 shares traded. MTBC, Inc. (NASDAQ:MTBC) has risen 0.64% since September 13, 2018 and is uptrending. It has outperformed by 0.64% the S&P500.

Medical Transcription Billing, Corp., a healthcare information technology company, provides an integrated suite of Web solutions and related business services to healthcare providers primarily in the United States. The company has market cap of $51.46 million. It principally offers PracticePro, a software-as-a-service platform, which includes practice management solutions and related tools that facilitate the day-to-day operation of a medical practice; electronic health record solutions, which enables clients to reduce paperwork and qualify for government incentives; revenue cycle management services, such as end-to-end medical billing, analytics, and related services; and mobile health solutions, including smartphone applications that assist patients and healthcare providers in the provision of healthcare services. It currently has negative earnings. The firm also provides ChartsPro, a Web EHR solution; transcription, coding, indexing, and other ancillary services; clearinghouse services, which enables clients to track claim status and includes batch electronic claim and payment transaction clearing services, as well as Web access for claim corrections; and electronic data interchange management system that audits, manages, and controls the exchange of information.

More notable recent MTBC, Inc. (NASDAQ:MTBC) news were published by: Nasdaq.com which released: “MTBC Deploys Video Telehealth Service to Clinicians Fighting Opioid Epidemic – Nasdaq” on September 10, 2019, also Globenewswire.com with their article: “MTBC Named One of the Top 10 RCM Solution Providers by Healthcare Tech Outlook – GlobeNewswire” published on September 18, 2018, Seekingalpha.com published: “Letter to Medical Transcription Billing Shareholders – Seeking Alpha” on July 17, 2017. More interesting news about MTBC, Inc. (NASDAQ:MTBC) were released by: Seekingalpha.com and their article: “MTBC, Inc. 2018 Q4 – Results – Earnings Call Slides – Seeking Alpha” published on March 20, 2019 as well as Finance.Yahoo.com‘s news article titled: “Is MTBC, Inc. (NASDAQ:MTBC) A Volatile Stock? – Yahoo Finance” with publication date: May 14, 2019.

MTBC, Inc. (NASDAQ:MTBC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.